MedChem Express

MedChem Express logo

MedChemExpress has an experienced team of custom synthesis chemists, led by an impressive group of Ph.D.'s. With this team, we have the capability of supporting all kinds of chemistry projects of multiple step syntheses of complex labeled molecules, including metabolites and steroids. Following scientific and technological innovation, challenging traditional thinking, MedChemExpress has always been committed to develop quality products that exceed international standards on cost and reliability, to create the most advanced synthetic route. With high experiences in preparing a large numbers of different biologically active molecules, we provide rapid synthesis of new products. That is why we can consistently deliver your custom synthesis compounds faster than any other company.

Company Website

Product Listing

(-)-Indolactam V 1mg  | ≥98%

MedChem Express

(-)-Indolactam V (ILV) is a protein kinase C activator, which strongly directs human ES cell-derived definitive endoderm into pancreatic endoderm. Target: PKC in vitro: Pancreatic endoderm induction by ILV alone has been shown to generate approximately 53% PDX1-positive cells, in contrast to 25% PDX1-positive cells achievable with standard inductors, FGF10, RA and CYC. Here, using […]

More Information Supplier Page

(-)-Indolactam V 5mg  | ≥98%

MedChem Express

(-)-Indolactam V (ILV) is a protein kinase C activator, which strongly directs human ES cell-derived definitive endoderm into pancreatic endoderm. Target: PKC in vitro: Pancreatic endoderm induction by ILV alone has been shown to generate approximately 53% PDX1-positive cells, in contrast to 25% PDX1-positive cells achievable with standard inductors, FGF10, RA and CYC. Here, using […]

More Information Supplier Page

(-)-Indolactam V 10mM/1mL  | ≥98%

MedChem Express

(-)-Indolactam V (ILV) is a protein kinase C activator, which strongly directs human ES cell-derived definitive endoderm into pancreatic endoderm. Target: PKC in vitro: Pancreatic endoderm induction by ILV alone has been shown to generate approximately 53% PDX1-positive cells, in contrast to 25% PDX1-positive cells achievable with standard inductors, FGF10, RA and CYC. Here, using […]

More Information Supplier Page

(-)-Ketoconazole 10mg  | ≥98%

MedChem Express

(-)-Ketoconazole is one of the enantiomer of Ketoconazole. Ketoconazole is a racemic mixture of two enantiomers, levoketoconazole ((2S,4R)-(−)-ketoconazole) and dextroketoconazole ((2R,4S)-(+)-ketoconazole).

More Information Supplier Page

(-)-Ketoconazole 50mg  | ≥98%

MedChem Express

(-)-Ketoconazole is one of the enantiomer of Ketoconazole. Ketoconazole is a racemic mixture of two enantiomers, levoketoconazole ((2S,4R)-(−)-ketoconazole) and dextroketoconazole ((2R,4S)-(+)-ketoconazole).

More Information Supplier Page

(-)-Ketoconazole 10mM/1mL  | ≥98%

MedChem Express

(-)-Ketoconazole is one of the enantiomer of Ketoconazole. Ketoconazole is a racemic mixture of two enantiomers, levoketoconazole ((2S,4R)-(−)-ketoconazole) and dextroketoconazole ((2R,4S)-(+)-ketoconazole).

More Information Supplier Page

(-)-MK 801 (Maleate) 10mM/1mL  | ≥98%

MedChem Express

(-)-MK 801 Maleate is the enantiomer of (+)-MK-801. (+)-MK 801 Maleate is a potent, selective and non-competitive NMDA receptor antagonist.

More Information Supplier Page

(-)-MK 801 (Maleate) 50mg  | ≥98%

MedChem Express

(-)-MK 801 Maleate is the enantiomer of (+)-MK-801. (+)-MK 801 Maleate is a potent, selective and non-competitive NMDA receptor antagonist.

More Information Supplier Page

(-)-MK 801 (Maleate) 10mg  | ≥98%

MedChem Express

(-)-MK 801 Maleate is the enantiomer of (+)-MK-801. (+)-MK 801 Maleate is a potent, selective and non-competitive NMDA receptor antagonist.

More Information Supplier Page

(-)-PX20606 trans isomer 1mg  | ≥98%

MedChem Express

(-)-PX20606 trans isomer is a FXR agonist with EC50s of 18 and 29 nM for FXR in FRET and M1H assay, respectively. IC50 & Target: EC50: 18 nM (FXR in FRET assay), 29 nM (FXR in M1H assay)[1]

More Information Supplier Page

(-)-PX20606 trans isomer 2mg  | ≥98%

MedChem Express

(-)-PX20606 trans isomer is a FXR agonist with EC50s of 18 and 29 nM for FXR in FRET and M1H assay, respectively. IC50 & Target: EC50: 18 nM (FXR in FRET assay), 29 nM (FXR in M1H assay)[1]

More Information Supplier Page

(-)-PX20606 trans isomer 10mM/1mL  | ≥98%

MedChem Express

(-)-PX20606 trans isomer is a FXR agonist with EC50s of 18 and 29 nM for FXR in FRET and M1H assay, respectively. IC50 & Target: EC50: 18 nM (FXR in FRET assay), 29 nM (FXR in M1H assay)[1]

More Information Supplier Page

(-)-Securinine 5mg  | ≥98%

MedChem Express

(-)-Securinine is plant-derived alkaloid and also a GABAA receptor antagonist. IC50 & Target: GABAA receptor[1] In Vitro: (-)-Securinine is a major plant-derived alkaloid and also a GABAA receptor antagonist. (-)-Securinine is significantly potent on HeLa cells growth inhibition with IC50 values of 7.02±0.52 μg/mL (32.3 μM). (-)-Securinine induces apoptosis in a dose-dependent manner in the […]

More Information Supplier Page

(-)-Securinine 10mg  | ≥98%

MedChem Express

(-)-Securinine is plant-derived alkaloid and also a GABAA receptor antagonist. IC50 & Target: GABAA receptor[1] In Vitro: (-)-Securinine is a major plant-derived alkaloid and also a GABAA receptor antagonist. (-)-Securinine is significantly potent on HeLa cells growth inhibition with IC50 values of 7.02±0.52 μg/mL (32.3 μM). (-)-Securinine induces apoptosis in a dose-dependent manner in the […]

More Information Supplier Page

(-)-Securinine 25mg  | ≥98%

MedChem Express

(-)-Securinine is plant-derived alkaloid and also a GABAA receptor antagonist. IC50 & Target: GABAA receptor[1] In Vitro: (-)-Securinine is a major plant-derived alkaloid and also a GABAA receptor antagonist. (-)-Securinine is significantly potent on HeLa cells growth inhibition with IC50 values of 7.02±0.52 μg/mL (32.3 μM). (-)-Securinine induces apoptosis in a dose-dependent manner in the […]

More Information Supplier Page

(-)-Securinine 10mM/1mL  | ≥98%

MedChem Express

(-)-Securinine is plant-derived alkaloid and also a GABAA receptor antagonist. IC50 & Target: GABAA receptor[1] In Vitro: (-)-Securinine is a major plant-derived alkaloid and also a GABAA receptor antagonist. (-)-Securinine is significantly potent on HeLa cells growth inhibition with IC50 values of 7.02±0.52 μg/mL (32.3 μM). (-)-Securinine induces apoptosis in a dose-dependent manner in the […]

More Information Supplier Page

(-)-Talarozole 5mg  | ≥98%

MedChem Express

(-)-Talarozole is a potent inhibitor of retinoic acid metabolism extracted from patent WO 1997049704 A1. IC50 & Target: retinoic acid[1]

More Information Supplier Page

(-)-Talarozole 1mg  | ≥98%

MedChem Express

(-)-Talarozole is a potent inhibitor of retinoic acid metabolism extracted from patent WO 1997049704 A1. IC50 & Target: retinoic acid[1]

More Information Supplier Page

(-)-Talarozole 10mg  | ≥98%

MedChem Express

(-)-Talarozole is a potent inhibitor of retinoic acid metabolism extracted from patent WO 1997049704 A1. IC50 & Target: retinoic acid[1]

More Information Supplier Page

(-)-Talarozole 25mg  | ≥98%

MedChem Express

(-)-Talarozole is a potent inhibitor of retinoic acid metabolism extracted from patent WO 1997049704 A1. IC50 & Target: retinoic acid[1]

More Information Supplier Page

(-)-Talarozole 50mg  | ≥98%

MedChem Express

(-)-Talarozole is a potent inhibitor of retinoic acid metabolism extracted from patent WO 1997049704 A1. IC50 & Target: retinoic acid[1]

More Information Supplier Page

(-)-Talarozole 10mM/1mL  | ≥98%

MedChem Express

(-)-Talarozole is a potent inhibitor of retinoic acid metabolism extracted from patent WO 1997049704 A1. IC50 & Target: retinoic acid[1]

More Information Supplier Page

(+)-Apogossypol 5mg  | ≥98%

MedChem Express

(+)-Apogossypol is a pan-BCL-2 antagonist. (+)-Apogossypol binds to Mcl-1, Bcl-2 and Bcl-xL with EC50s of 2.6, 2.8 and 3.69 µM, respectively. IC50 & Target: EC50: 2.60 µM (Mcl-1), 2.80 µM (Bcl-2), 3.69 µM (Bcl-xL)[1] Kd: 1.70 µM (Bcl-xL)[1] In Vitro: In agreement with NMR binding and fluorescence polarization assays (FPAs) data, (+)-Apogossypol displays potent binding […]

More Information Supplier Page

(+)-Apogossypol 10mg  | ≥98%

MedChem Express

(+)-Apogossypol is a pan-BCL-2 antagonist. (+)-Apogossypol binds to Mcl-1, Bcl-2 and Bcl-xL with EC50s of 2.6, 2.8 and 3.69 µM, respectively. IC50 & Target: EC50: 2.60 µM (Mcl-1), 2.80 µM (Bcl-2), 3.69 µM (Bcl-xL)[1] Kd: 1.70 µM (Bcl-xL)[1] In Vitro: In agreement with NMR binding and fluorescence polarization assays (FPAs) data, (+)-Apogossypol displays potent binding […]

More Information Supplier Page

(+)-Borneol 100mg  | ≥98%

MedChem Express

(+)-Borneol (d-Borneol) is a natural bicyclic monoterpene used for analgesia and anesthesia in traditional Chinese medicine; enhances GABA receptor activity with an EC50 of 248 μM. IC50 & Target: EC50: 248 μM (GABA receptor)[1] In Vitro: (+)-Borneol is present in the essential oils of numerous medicinal plants, including valerian (Valeriana officinalis), chamomile (Matricaria chamomilla) and […]

More Information Supplier Page

(+)-Borneol 10mM/1mL  | ≥98%

MedChem Express

(+)-Borneol (d-Borneol) is a natural bicyclic monoterpene used for analgesia and anesthesia in traditional Chinese medicine; enhances GABA receptor activity with an EC50 of 248 μM. IC50 & Target: EC50: 248 μM (GABA receptor)[1] In Vitro: (+)-Borneol is present in the essential oils of numerous medicinal plants, including valerian (Valeriana officinalis), chamomile (Matricaria chamomilla) and […]

More Information Supplier Page

(+)-Catechin hydrate 10mM/1mL  | ≥98%

MedChem Express

(+)-Catechin hydrate inhibits cyclooxygenase-1 (COX-1) with an IC50 of 1.4 μM. IC50 & Target: IC50: 1.4 uM (COX-1)[1] In Vitro: (+)-Catechin exhibits >95% inhibitory activity at 70 μg/mL against cyclooxygenase-1 (COX-1) with an IC50 of 1.4 μM[1]. A dose-dependent reduction in color is observed after 24 hours of treatment with (+)-Catechin, and 54.76% of the […]

More Information Supplier Page

(+)-Catechin hydrate 100mg  | ≥98%

MedChem Express

(+)-Catechin hydrate inhibits cyclooxygenase-1 (COX-1) with an IC50 of 1.4 μM. IC50 & Target: IC50: 1.4 uM (COX-1)[1] In Vitro: (+)-Catechin exhibits >95% inhibitory activity at 70 μg/mL against cyclooxygenase-1 (COX-1) with an IC50 of 1.4 μM[1]. A dose-dependent reduction in color is observed after 24 hours of treatment with (+)-Catechin, and 54.76% of the […]

More Information Supplier Page

(+)-Cevimeline (hydrochloride hemihydrate) 10mM/1mL  | ≥98%

MedChem Express

Cevimeline hydrochloride hemihydrate, a novel muscarinic receptor agonist, is a candidate therapeutic drug for xerostomia in Sjogren’s syndrome. IC50 value: Target: mAChR The general pharmacol. properties of this drug on the gastrointestinal, urinary, and reproductive systems and other tissues were investigated in mice, rats, guinea pigs, rabbits, and dogs. The in vitro metab. of SNI-2011 […]

More Information Supplier Page

(+)-Cevimeline (hydrochloride hemihydrate) 1mg  | ≥98%

MedChem Express

Cevimeline hydrochloride hemihydrate, a novel muscarinic receptor agonist, is a candidate therapeutic drug for xerostomia in Sjogren’s syndrome. IC50 value: Target: mAChR The general pharmacol. properties of this drug on the gastrointestinal, urinary, and reproductive systems and other tissues were investigated in mice, rats, guinea pigs, rabbits, and dogs. The in vitro metab. of SNI-2011 […]

More Information Supplier Page

(+)-Cevimeline (hydrochloride hemihydrate) 5mg  | ≥98%

MedChem Express

Cevimeline hydrochloride hemihydrate, a novel muscarinic receptor agonist, is a candidate therapeutic drug for xerostomia in Sjogren’s syndrome. IC50 value: Target: mAChR The general pharmacol. properties of this drug on the gastrointestinal, urinary, and reproductive systems and other tissues were investigated in mice, rats, guinea pigs, rabbits, and dogs. The in vitro metab. of SNI-2011 […]

More Information Supplier Page